Analytical Data
-
Gene name
THSD1
- Application
-
Alternative Names
THSD1；TMTSP；Thrombospondin type-1 domain-containing Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NS62
-
Expression Region
25-361aa
-
AA Sequence
EYLLLREPGHVALSNDTVYVDFQYFDGANGTLRNVSVLLLEANTNQTVTT KYLLTNQSQGTLKFECFYFKEAGDYWFTMTPEATDNSTPFPWWEKSAFLK VEWPVFHVDLNRSAKAAEGTFQVGLFTSQPLCPFPVDKPNIVVDVIFTNS LPEARRNSRQPLEIRTSKRTELAQGQWVEFGCAPLGPEAYVTVVLKLLGR DSVITSTGPIDLAQKFGYKLVMVPELTCESGVEVTVLPPPCTFVQGVVTV FKEAPRYPGKRTIHLAENSLPLGERRTIFNCTLFDMGKNKYCFDFGISSR SHFSAKEECMLIQRNTAFQPSSPSPLQPQGPVKSNNIVDHHHHHH
-
Molecular Weight
39 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
THSD1, or Thrombospondin Type-1 Domain Containing 1, is a protein implicated in various biological processes, including angiogenesis, cell adhesion, and tissue remodeling. Its expression has been linked to a variety of pathological conditions, such as cancer and cardiovascular diseases. Recent studies have shown that THSD1 plays a critical role in tumor microenvironments, affecting both tumor growth and metastatic potential. Due to its involvement in these critical biological processes, THSD1 has garnered attention as a potential biomarker and therapeutic target. The recombinant expression of THSD1 allows for the study of its structure and function in detail, facilitating the understanding of its role in disease mechanisms. By producing THSD1 as a recombinant protein, researchers can explore its interactions with other cellular components, assess its effects on cell behavior, and evaluate its potential as a therapeutic agent in the modulation of disease progression. The ongoing research into THSD1 aims to elucidate its biological significance and therapeutic applicability, paving the way for innovative strategies in disease treatment and management.
